StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report published on Saturday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
Shares of SRNE stock opened at $0.00 on Friday. Sorrento Therapeutics has a fifty-two week low of $0.00 and a fifty-two week high of $0.08.
Sorrento Therapeutics Company Profile
Want More Great Investing Ideas?
Featured Stories
- Five stocks we like better than Sorrento Therapeutics
- EV Stocks and How to Profit from Them
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What Are Trending Stocks? Trending Stocks Explained
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- The Basics of Support and Resistance
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.